Diabetes Foot Africa Region Registry ((D-FAR))

Getz Pharma

Status: Not yet enrolling

Conditions: Diabetes

Study type: Observational

Funder types: Industry

Identifiers

NCT07031141

GETZ-DF-01-24

Details and patient eligibility

About

D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.

Full description

Among the various complications, those related to diabetic foot disease are associated with the highest morbidity and mortality. Diabetic foot problems are characterized by infection, ulceration and/or destruction of deep tissue in the foot and are usually associated with neurological abnormalities and varying degrees of peripheral arterial disease (PAD) in the lower limb. the purpose of collect comprehensive data on the clinical features, management strategies, and outcomes of patients with diabetic foot complications.

Enrollment: 2,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Male and female patients
2. Residents of participating African countries.
3. Diagnosed with diabetic foot complications (e.g., ulcers, gangrene, infection, ischemia).
4. Patients with a history of foot ulcers or amputations due to diabetes.
5. High-risk patients with peripheral neuropathy and/or peripheral arterial disease.

Exclusion criteria

1. Non-diabetic foot complications.
2. Acute traumatic injuries unrelated to diabetes.
3. Patients unwilling to provide informed consent.